The correlation of NDUFS1 with clinicopathological variables of GC, such as gender and age of patients, as well as tumor size, differentiation, lymph node metastasis, and Tumor Node Metastasis (TNM) stage, was then evaluated. Here, NDUFS1 is linked to metastatic malignant neoplasm in the lymph nodes.